Jessica Rigg
Nurse Practitioner · Herrin, ILNPI 1710586128
Payments from drug & device makers
Across 490 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- GSK$655
- AstraZeneca$580
- Lilly USA, LLC$476
- Pfizer$422
- Amgen$350
- plus $4K from 33 others
What the payments were for
- Food & beverage$7,920100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 79 | $1,164 |
| GSK | 47 | $655 |
| AstraZeneca | 28 | $580 |
| Lilly USA, LLC | 32 | $476 |
| Pfizer | 29 | $422 |
| Amgen | 36 | $350 |
| Novartis | 21 | $316 |
| Novo Nordisk | 18 | $294 |
| Mylan Specialty L.p. | 16 | $261 |
| Braeburn Inc. | 11 | $243 |
| Merck | 12 | $237 |
| Dexcom, Inc. | 11 | $234 |
| Lundbeck LLC | 13 | $215 |
| Bayer | 16 | $208 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $183 |
| Axsome Therapeutics, Inc. | 6 | $183 |
| Indivior Inc. | 8 | $170 |
| Phathom Pharmaceuticals, Inc. | 5 | $169 |
| Electromed, Inc. | 22 | $166 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $165 |
| Otsuka America Pharmaceutical, Inc. | 7 | $159 |
| Vanda Pharmaceuticals Inc. | 4 | $140 |
| Viiv Healthcare Company | 5 | $132 |
| Sunovion Pharmaceuticals Inc. | 7 | $115 |
| Sanofi-aventis U.S. LLC | 1 | $98 |
| Sumitomo Pharma America, Inc. | 4 | $73 |
| Johnson & Johnson | 4 | $67 |
| Seqirus USA Inc | 2 | $58 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $57 |
| Insulet Corporation | 3 | $54 |
| Exact Sciences | 3 | $52 |
| Amarin Pharma, Inc. | 2 | $36 |
| Organon | 4 | $36 |
| Boehringer Ingelheim | 2 | $31 |
| Exeltis, USA Inc. | 2 | $28 |
| Grifols USA, LLC | 1 | $25 |
| Viatris Specialty LLC | 1 | $24 |
| Boston Scientific | 1 | $23 |
| Impel Pharmaceuticals Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,920 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 94 | $103,118 |
| JardianceEmpagliflozin | 67 | $86,956 |
| TrulicityDulaglutide | 52 | $57,563 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 45 | $32,412 |
| FarxigaDapagliflozin Propanediol | 26 | $31,436 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $31,166 |
| EliquisApixaban | 35 | $28,179 |
| VraylarCariprazine Hcl | 12 | $17,869 |
| MounjaroTirzepatide | 13 | $11,922 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $7,455 |
| Spiriva HandihalerTiotropium Bromide | 13 | $6,766 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $6,285 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $3,600 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 43 | $3,519 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 159 | $2,929 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $294 | $103,11894 claims |
| Boehringer IngelheimJardiance | $31 | $86,95667 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $476 | $69,48465 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $580 | $67,44783 claims |
| GSKTrelegy Ellipta, Incruse Ellipta, Anoro Ellipta | $655 | $44,90649 claims |
| PfizerEliquis | $422 | $28,17935 claims |
| AbbVieVraylar | $1,164 | $17,86912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Other nurse practitioner in Herrin
- Erika VuckoChicago$417K
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Kristy LukeChicago$77K
- Yvonna OldakerFlossmoor$74K
- Heather PiercePekin$72K
- Dara McKinleyEvanston$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.